本期我们就来介绍一下莫德纳公司的mRNA-1608，这是一种针对复发性生殖器疱疹的治疗性疫苗。有不少人认为mRNA-1608将会是最先上市的生殖器疱疹治疗 ...
Moderna said earlier this year that its HSV shot – codenamed mRNA-1608 – had started a first-in-human phase 1/2 trial to establish safety and proof-of-concept efficacy in around 365 adults 18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback